TY - JOUR
T1 - CD4+T cells sustain aggressive chronic lymphocytic leukemia in Em- TCL1 mice through a CD40L-independent mechanism
AU - Grioni, Matteo
AU - Brevi, Arianna
AU - Cattaneo, Elena
AU - Rovida, Alessandra
AU - Bordini, Jessica
AU - Bertilaccio, Maria Teresa Sabrina
AU - Ponzoni, Maurilio
AU - Casorati, Giulia
AU - Dellabona, Paolo
AU - Ghia, Paolo
AU - Bellone, Matteo
AU - Calcinotto, Arianna
N1 - Funding Information:
This work was supported by Fondazione Associazione Italiana per la Ricerca sul Cancro, AIRC (FIRC) 5 per 1000 Molecular Clinical Oncology Special Program (grant 9965) (M.B., P.D., G.C., and P.G.) and 5 per 1000 2019 (grant 22737) (P.D.). A.C. and A.B. were awarded a fellowship from AIRC/FIRC.
Publisher Copyright:
© 2021 American Society of Hematology. All rights reserved.
PY - 2021/7/27
Y1 - 2021/7/27
N2 - Chronic lymphocytic leukemia (CLL) is caused by the progressive accumulation of mature CD5+B cells in secondary lymphoid organs. In vitro data suggest that CD4+T lymphocytes also sustain survival and proliferation of CLL clones through CD40L/CD40 interactions. In vivo data in animal models are conflicting. To clarify this clinically relevant biological issue, we generated genetically modified Eμ-TCL1 mice lacking CD41 T cells (TCL1+/+AB0), CD40 (TCL1+/+CD40-/-), or CD8+T cells (TCL1+/+TAP-/-), and we monitored the appearance and progression of a disease that mimics aggressive human CLL by flow cytometry and immunohistochemical analyses. Findings were confirmed by adoptive transfer of leukemic cells into mice lacking CD4+T cells or CD40L or mice treated with antibodies depleting CD4 T cells or blocking CD40L/CD40 interactions. CLL clones did not proliferate in mice lacking or depleted of CD41 T cells, thus confirming that CD4+T cells are essential for CLL development. By contrast, CD8+T cells exerted an antitumor activity, as indicated by the accelerated disease progression in TCL1+/+TAP-/-mice. Antigen specificity of CD4+T cells was marginal for CLL development, because CLL clones efficiently proliferated in transgenic mice whose CD4 T cells had a T-cell receptor with CLL-unrelated specificities. Leukemic clones also proliferated when transferred into wild-type mice treated with monoclonal antibodies blocking CD40 or into CD40L-/-mice, and TCL1+/+CD40-/-mice developed frank CLL. Our data demonstrate that CD81 T cells restrain CLL progression, whereas CD41 T cells support the growth of leukemic clones in TCL1 mice through CD40-independent and apparently noncognate mechanisms.
AB - Chronic lymphocytic leukemia (CLL) is caused by the progressive accumulation of mature CD5+B cells in secondary lymphoid organs. In vitro data suggest that CD4+T lymphocytes also sustain survival and proliferation of CLL clones through CD40L/CD40 interactions. In vivo data in animal models are conflicting. To clarify this clinically relevant biological issue, we generated genetically modified Eμ-TCL1 mice lacking CD41 T cells (TCL1+/+AB0), CD40 (TCL1+/+CD40-/-), or CD8+T cells (TCL1+/+TAP-/-), and we monitored the appearance and progression of a disease that mimics aggressive human CLL by flow cytometry and immunohistochemical analyses. Findings were confirmed by adoptive transfer of leukemic cells into mice lacking CD4+T cells or CD40L or mice treated with antibodies depleting CD4 T cells or blocking CD40L/CD40 interactions. CLL clones did not proliferate in mice lacking or depleted of CD41 T cells, thus confirming that CD4+T cells are essential for CLL development. By contrast, CD8+T cells exerted an antitumor activity, as indicated by the accelerated disease progression in TCL1+/+TAP-/-mice. Antigen specificity of CD4+T cells was marginal for CLL development, because CLL clones efficiently proliferated in transgenic mice whose CD4 T cells had a T-cell receptor with CLL-unrelated specificities. Leukemic clones also proliferated when transferred into wild-type mice treated with monoclonal antibodies blocking CD40 or into CD40L-/-mice, and TCL1+/+CD40-/-mice developed frank CLL. Our data demonstrate that CD81 T cells restrain CLL progression, whereas CD41 T cells support the growth of leukemic clones in TCL1 mice through CD40-independent and apparently noncognate mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=85111220591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111220591&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2020003795
DO - 10.1182/bloodadvances.2020003795
M3 - Article
C2 - 34269799
AN - SCOPUS:85111220591
SN - 2473-9529
VL - 5
SP - 2017
EP - 2028
JO - Blood Advances
JF - Blood Advances
IS - 14
ER -